1. Home
  2. INSP vs LAZ Comparison

INSP vs LAZ Comparison

Compare INSP & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSP
  • LAZ
  • Stock Information
  • Founded
  • INSP 2007
  • LAZ 1848
  • Country
  • INSP United States
  • LAZ United States
  • Employees
  • INSP N/A
  • LAZ N/A
  • Industry
  • INSP Medical/Dental Instruments
  • LAZ Investment Managers
  • Sector
  • INSP Health Care
  • LAZ Finance
  • Exchange
  • INSP Nasdaq
  • LAZ Nasdaq
  • Market Cap
  • INSP 5.2B
  • LAZ 5.3B
  • IPO Year
  • INSP 2018
  • LAZ 2005
  • Fundamental
  • Price
  • INSP $172.77
  • LAZ $54.98
  • Analyst Decision
  • INSP Buy
  • LAZ Hold
  • Analyst Count
  • INSP 11
  • LAZ 7
  • Target Price
  • INSP $226.18
  • LAZ $53.00
  • AVG Volume (30 Days)
  • INSP 570.0K
  • LAZ 938.4K
  • Earning Date
  • INSP 11-04-2024
  • LAZ 10-31-2024
  • Dividend Yield
  • INSP N/A
  • LAZ 3.64%
  • EPS Growth
  • INSP N/A
  • LAZ N/A
  • EPS
  • INSP 1.09
  • LAZ 2.55
  • Revenue
  • INSP $755,594,000.00
  • LAZ $3,047,514,000.00
  • Revenue This Year
  • INSP $29.96
  • LAZ $14.99
  • Revenue Next Year
  • INSP $19.42
  • LAZ $13.14
  • P/E Ratio
  • INSP $157.93
  • LAZ $21.53
  • Revenue Growth
  • INSP 32.52
  • LAZ 25.34
  • 52 Week Low
  • INSP $123.00
  • LAZ $26.25
  • 52 Week High
  • INSP $257.40
  • LAZ $61.14
  • Technical
  • Relative Strength Index (RSI)
  • INSP 34.22
  • LAZ 53.58
  • Support Level
  • INSP $196.12
  • LAZ $54.59
  • Resistance Level
  • INSP $204.93
  • LAZ $60.35
  • Average True Range (ATR)
  • INSP 10.27
  • LAZ 2.05
  • MACD
  • INSP -2.67
  • LAZ -0.07
  • Stochastic Oscillator
  • INSP 5.77
  • LAZ 43.02

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

About LAZ Lazard Inc.

Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.

Share on Social Networks: